GE HealthCare Technologies Inc. (GEHC) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $74.67. It has a SharesGrow Score of 65/100, indicating a above average investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of GEHC = $95.14 (+27.4% from the current price, the stock appears undervalued). Analyst consensus target is GEHC = $92 (+22.8% upside).
Valuation: GEHC trades at a trailing Price-to-Earnings (P/E) of 19.5 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.87.
Financials: revenue is $20.6B, +4%/yr average growth. Net income is $2.1B, growing at +4.5%/yr. Net profit margin is 10.1% (healthy). Gross margin is 40% (+0.9 pp trend).
Balance sheet: total debt is $10.0B against $10.4B equity (Debt-to-Equity (D/E) ratio 0.96, moderate). Current ratio is 1.18 (adequate). Debt-to-assets is 27.1%. Total assets: $36.9B.
Analyst outlook: 11 / 17 analysts rate GEHC as buy (65%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 66/100 (Pass), Growth 45/100 (Partial), Past 100/100 (Pass), Health 50/100 (Partial), Moat 73/100 (Pass), Future 67/100 (Pass), Income 55/100 (Partial).
